ArticleOncoTargets and therapy2018

Vandetanib (ZD6474) induces antiangiogenesis through mTOR-HIF-1 alpha-VEGF signaling axis in breast cancer cells.

Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.